Showing results (81-90 of 403) with videos related to

Sort By:
Pageof 41
Mabs|February 25, 2016
Differential killing of CD56-expressing cells by drug-conjugated human antibodies targeting membrane-distal and membrane-proximal non-overlapping epitopesYang Feng, Yanping Wang, Zhongyu Zhu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 20, 2007
Topotecan is active against Wilms' tumor: results of a multi-institutional phase II studyMonika L Metzger, Clinton F Stewart, Burgess B Freeman, et al.
Molecular Pharmacology|September 27, 2006
The H+-linked monocarboxylate transporter (MCT1/SLC16A1): a potential therapeutic target for high-risk neuroblastomaJun Fang, Quintin J Quinones, Trevor L Holman, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 3, 2019
PARP-1-Targeted Auger Emitters Display High-LET Cytotoxic Properties In Vitro but Show Limited Therapeutic Utility in Solid Tumor Models of Human NeuroblastomaHwan Lee, Aladdin Riad, Paul Martorano, et al.
Frontiers in Immunology|April 8, 2020
Immunogenicity and Immune Silence in Human CancerMark Yarmarkovich, Alvin Farrel, Artemio Sison, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2007
Prominent microvascular proliferation in clinically aggressive neuroblastomaRadhika Peddinti, Rana Zeine, Dragos Luca, et al.
Journal of Cellular Biochemistry|October 4, 2005
Anticancer effects of the novel 1alpha, 25-dihydroxyvitamin D3 hybrid analog QW1624F2-2 in human neuroblastomaC Damodar Reddy, Ratnakar Patti, Asha Guttapalli, et al.
Bioinformatics (Oxford, England)|May 21, 2005
CGHAnalyzer: a stand-alone software package for cancer genome analysis using array-based DNA copy number dataAdam A Margolin, Joel Greshock, Tara L Naylor, et al.
Cancer Research|April 3, 2003
ID2 expression is not associated with MYCN amplification or expression in human neuroblastomasQun Wang, George Hii, Suzanne Shusterman, et al.
Cancer Research|November 9, 2012
Combination therapy targeting the Chk1 and Wee1 kinases shows therapeutic efficacy in neuroblastomaMike R Russell, Kirill Levin, JulieAnn Rader, et al.
Pageof 41